nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—ADRB2—polycystic ovary syndrome	0.803	1	CbGaD
Dobutamine—CA5A—endocrine gland—polycystic ovary syndrome	0.00383	0.103	CbGeAlD
Dobutamine—Fenoterol—ADRB3—polycystic ovary syndrome	0.00241	0.196	CrCbGaD
Dobutamine—Arbutamine—ADRB3—polycystic ovary syndrome	0.00226	0.184	CrCbGaD
Dobutamine—COMT—adrenal cortex—polycystic ovary syndrome	0.00219	0.0585	CbGeAlD
Dobutamine—COMT—endometrium—polycystic ovary syndrome	0.00195	0.0522	CbGeAlD
Dobutamine—CA5B—adipose tissue—polycystic ovary syndrome	0.00191	0.0511	CbGeAlD
Dobutamine—COMT—uterus—polycystic ovary syndrome	0.0018	0.0481	CbGeAlD
Dobutamine—COMT—pituitary gland—polycystic ovary syndrome	0.00177	0.0473	CbGeAlD
Dobutamine—COMT—adipose tissue—polycystic ovary syndrome	0.00176	0.0471	CbGeAlD
Dobutamine—CA5B—adrenal gland—polycystic ovary syndrome	0.00171	0.0458	CbGeAlD
Dobutamine—CA2—embryo—polycystic ovary syndrome	0.00166	0.0443	CbGeAlD
Dobutamine—Labetalol—ADRB3—polycystic ovary syndrome	0.0016	0.13	CrCbGaD
Dobutamine—CA5B—vagina—polycystic ovary syndrome	0.00159	0.0425	CbGeAlD
Dobutamine—COMT—adrenal gland—polycystic ovary syndrome	0.00158	0.0422	CbGeAlD
Dobutamine—ADRB1—adipose tissue—polycystic ovary syndrome	0.00149	0.0399	CbGeAlD
Dobutamine—CA5B—endocrine gland—polycystic ovary syndrome	0.00149	0.0397	CbGeAlD
Dobutamine—COMT—female gonad—polycystic ovary syndrome	0.00147	0.0394	CbGeAlD
Dobutamine—COMT—vagina—polycystic ovary syndrome	0.00146	0.0391	CbGeAlD
Dobutamine—COMT—endocrine gland—polycystic ovary syndrome	0.00137	0.0366	CbGeAlD
Dobutamine—CA2—adrenal cortex—polycystic ovary syndrome	0.00136	0.0363	CbGeAlD
Dobutamine—ADRB1—endocrine gland—polycystic ovary syndrome	0.00116	0.031	CbGeAlD
Dobutamine—CA2—pituitary gland—polycystic ovary syndrome	0.0011	0.0294	CbGeAlD
Dobutamine—CA2—adipose tissue—polycystic ovary syndrome	0.00109	0.0292	CbGeAlD
Dobutamine—Masoprocol—CYP19A1—polycystic ovary syndrome	0.00104	0.085	CrCbGaD
Dobutamine—CA2—adrenal gland—polycystic ovary syndrome	0.000981	0.0262	CbGeAlD
Dobutamine—Ritodrine—ADRB2—polycystic ovary syndrome	0.000918	0.0747	CrCbGaD
Dobutamine—Fenoterol—ADRB2—polycystic ovary syndrome	0.000918	0.0747	CrCbGaD
Dobutamine—CA2—female gonad—polycystic ovary syndrome	0.000914	0.0245	CbGeAlD
Dobutamine—CA2—vagina—polycystic ovary syndrome	0.000909	0.0243	CbGeAlD
Dobutamine—Arbutamine—ADRB2—polycystic ovary syndrome	0.000858	0.0698	CrCbGaD
Dobutamine—CA2—endocrine gland—polycystic ovary syndrome	0.00085	0.0227	CbGeAlD
Dobutamine—Arformoterol—ADRB2—polycystic ovary syndrome	0.000833	0.0678	CrCbGaD
Dobutamine—Formoterol—ADRB2—polycystic ovary syndrome	0.000833	0.0678	CrCbGaD
Dobutamine—Labetalol—ADRB2—polycystic ovary syndrome	0.000609	0.0496	CrCbGaD
Dobutamine—CA5B—Metabolism—CYP11A1—polycystic ovary syndrome	0.000142	0.000963	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000141	0.000959	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000141	0.000958	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000141	0.000958	CbGpPWpGaD
Dobutamine—COMT—Metabolism—STAR—polycystic ovary syndrome	0.000141	0.000955	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000139	0.000944	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000139	0.000943	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000138	0.000937	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000138	0.000937	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000138	0.000936	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000136	0.000922	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000135	0.000916	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKR1C3—polycystic ovary syndrome	0.000134	0.000909	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000133	0.000904	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000132	0.000896	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYP17A1—polycystic ovary syndrome	0.000132	0.000895	CbGpPWpGaD
Dobutamine—CA2—Metabolism—LHB—polycystic ovary syndrome	0.00013	0.000884	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000129	0.000877	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000128	0.00087	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000128	0.00087	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000128	0.00087	CbGpPWpGaD
Dobutamine—CA2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000127	0.000864	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000125	0.000851	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000125	0.000851	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000125	0.000851	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HMMR—polycystic ovary syndrome	0.000125	0.000851	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000125	0.000846	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000123	0.000836	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—TH—polycystic ovary syndrome	0.000122	0.000829	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000122	0.000828	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00012	0.000814	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HSD3B1—polycystic ovary syndrome	0.00012	0.000812	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000119	0.000807	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000117	0.000796	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000116	0.00079	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000114	0.000775	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—TH—polycystic ovary syndrome	0.000114	0.000774	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000114	0.000773	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000114	0.00077	CbGpPWpGaD
Dobutamine—CA2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000113	0.00077	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000113	0.000769	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000112	0.000759	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000111	0.000753	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—SLC2A4—polycystic ovary syndrome	0.000111	0.000753	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000111	0.000752	CbGpPWpGaD
Dobutamine—CA2—Metabolism—RRM2—polycystic ovary syndrome	0.00011	0.000746	CbGpPWpGaD
Dobutamine—COMT—Metabolism—LHB—polycystic ovary syndrome	0.000109	0.00074	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HSD3B2—polycystic ovary syndrome	0.000107	0.000724	CbGpPWpGaD
Dobutamine—CA2—Metabolism—YAP1—polycystic ovary syndrome	0.000106	0.000719	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000105	0.000713	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYP19A1—polycystic ovary syndrome	0.000104	0.000708	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000104	0.000705	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000103	0.000701	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKR1C1—polycystic ovary syndrome	0.000103	0.000701	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000103	0.000699	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000103	0.000697	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NAMPT—polycystic ovary syndrome	0.000102	0.00069	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000102	0.000689	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000101	0.000686	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000101	0.000684	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000101	0.000682	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GNAS—polycystic ovary syndrome	9.98e-05	0.000677	CbGpPWpGaD
Dobutamine—COMT—Metabolism—SULT2A1—polycystic ovary syndrome	9.51e-05	0.000645	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—NCOR1—polycystic ovary syndrome	9.51e-05	0.000645	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKR1C3—polycystic ovary syndrome	9.49e-05	0.000644	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	9.46e-05	0.000641	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	9.39e-05	0.000637	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP17A1—polycystic ovary syndrome	9.34e-05	0.000634	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GNAS—polycystic ovary syndrome	9.32e-05	0.000632	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	9.25e-05	0.000628	CbGpPWpGaD
Dobutamine—COMT—Metabolism—RRM2—polycystic ovary syndrome	9.21e-05	0.000625	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	9.18e-05	0.000623	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	9.1e-05	0.000617	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	9.08e-05	0.000616	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYP1A1—polycystic ovary syndrome	9.01e-05	0.000612	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	8.99e-05	0.00061	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	8.9e-05	0.000604	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	8.88e-05	0.000602	CbGpPWpGaD
Dobutamine—COMT—Metabolism—YAP1—polycystic ovary syndrome	8.88e-05	0.000602	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—NCOR1—polycystic ovary syndrome	8.88e-05	0.000602	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	8.8e-05	0.000597	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	8.79e-05	0.000596	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	8.7e-05	0.00059	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	8.6e-05	0.000583	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	8.59e-05	0.000583	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NAMPT—polycystic ovary syndrome	8.53e-05	0.000579	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	8.43e-05	0.000572	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP11A1—polycystic ovary syndrome	8.42e-05	0.000571	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYP1A1—polycystic ovary syndrome	8.42e-05	0.000571	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MTHFR—polycystic ovary syndrome	8.4e-05	0.00057	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	8.4e-05	0.00057	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	8.27e-05	0.000561	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	8.24e-05	0.000559	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.21e-05	0.000557	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	8.17e-05	0.000554	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	8.09e-05	0.000549	CbGpPWpGaD
Dobutamine—CA2—Metabolism—TH—polycystic ovary syndrome	8.09e-05	0.000548	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.07e-05	0.000547	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.04e-05	0.000545	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.03e-05	0.000545	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	7.99e-05	0.000542	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	7.98e-05	0.000542	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKR1C3—polycystic ovary syndrome	7.95e-05	0.00054	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	7.89e-05	0.000535	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	7.87e-05	0.000534	CbGpPWpGaD
Dobutamine—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	7.87e-05	0.000534	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MTHFR—polycystic ovary syndrome	7.85e-05	0.000532	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP17A1—polycystic ovary syndrome	7.83e-05	0.000531	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	7.81e-05	0.00053	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	7.65e-05	0.000519	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.58e-05	0.000514	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.58e-05	0.000514	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	7.49e-05	0.000508	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.41e-05	0.000503	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.41e-05	0.000503	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	7.39e-05	0.000502	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.3e-05	0.000495	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.14e-05	0.000485	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.13e-05	0.000484	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.09e-05	0.000481	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	6.98e-05	0.000473	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	6.93e-05	0.00047	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.88e-05	0.000467	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPARG—polycystic ovary syndrome	6.81e-05	0.000462	CbGpPWpGaD
Dobutamine—COMT—Metabolism—TH—polycystic ovary syndrome	6.78e-05	0.00046	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.73e-05	0.000457	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—POMC—polycystic ovary syndrome	6.72e-05	0.000456	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.69e-05	0.000454	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—INS—polycystic ovary syndrome	6.68e-05	0.000453	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GNAS—polycystic ovary syndrome	6.6e-05	0.000448	CbGpPWpGaD
Dobutamine—COMT—Metabolism—SLC2A4—polycystic ovary syndrome	6.59e-05	0.000447	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.55e-05	0.000444	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	6.52e-05	0.000442	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	6.38e-05	0.000433	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPARG—polycystic ovary syndrome	6.36e-05	0.000432	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NCOR1—polycystic ovary syndrome	6.29e-05	0.000427	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—POMC—polycystic ovary syndrome	6.27e-05	0.000426	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—INS—polycystic ovary syndrome	6.24e-05	0.000423	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP19A1—polycystic ovary syndrome	6.2e-05	0.00042	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.09e-05	0.000413	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	5.96e-05	0.000404	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.96e-05	0.000404	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.94e-05	0.000403	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.81e-05	0.000394	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MTHFR—polycystic ovary syndrome	5.56e-05	0.000377	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	5.55e-05	0.000376	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GNAS—polycystic ovary syndrome	5.53e-05	0.000375	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	5.43e-05	0.000368	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	5.43e-05	0.000368	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.39e-05	0.000366	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	5.31e-05	0.00036	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.27e-05	0.000358	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NCOR1—polycystic ovary syndrome	5.27e-05	0.000357	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.21e-05	0.000354	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.1e-05	0.000346	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.07e-05	0.000344	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP1A1—polycystic ovary syndrome	4.99e-05	0.000339	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.96e-05	0.000337	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	4.94e-05	0.000335	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.92e-05	0.000333	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.88e-05	0.000331	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	4.84e-05	0.000328	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	4.82e-05	0.000327	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.78e-05	0.000324	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	4.72e-05	0.00032	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.72e-05	0.00032	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MTHFR—polycystic ovary syndrome	4.66e-05	0.000316	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.61e-05	0.000313	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.57e-05	0.00031	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.56e-05	0.000309	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	4.52e-05	0.000307	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—polycystic ovary syndrome	4.51e-05	0.000306	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.47e-05	0.000303	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.46e-05	0.000303	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.46e-05	0.000302	CbGpPWpGaD
Dobutamine—CA2—Metabolism—POMC—polycystic ovary syndrome	4.44e-05	0.000301	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	4.42e-05	0.0003	CbGpPWpGaD
Dobutamine—CA2—Metabolism—INS—polycystic ovary syndrome	4.42e-05	0.0003	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.31e-05	0.000293	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.24e-05	0.000288	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.22e-05	0.000286	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.2e-05	0.000285	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.15e-05	0.000281	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.14e-05	0.000281	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.11e-05	0.000279	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.05e-05	0.000275	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.92e-05	0.000266	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.87e-05	0.000263	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.84e-05	0.00026	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.79e-05	0.000257	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—polycystic ovary syndrome	3.78e-05	0.000256	CbGpPWpGaD
Dobutamine—COMT—Metabolism—POMC—polycystic ovary syndrome	3.72e-05	0.000253	CbGpPWpGaD
Dobutamine—COMT—Metabolism—INS—polycystic ovary syndrome	3.7e-05	0.000251	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	3.7e-05	0.000251	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	3.62e-05	0.000246	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.52e-05	0.000239	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.46e-05	0.000235	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.44e-05	0.000233	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	3.43e-05	0.000232	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.39e-05	0.00023	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	3.35e-05	0.000227	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.19e-05	0.000216	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.19e-05	0.000216	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.12e-05	0.000211	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.12e-05	0.000211	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.07e-05	0.000208	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.04e-05	0.000206	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3e-05	0.000204	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	2.97e-05	0.000202	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.96e-05	0.000201	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.95e-05	0.0002	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.9e-05	0.000197	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.89e-05	0.000196	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.8e-05	0.00019	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.79e-05	0.000189	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	2.78e-05	0.000189	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.74e-05	0.000186	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.73e-05	0.000185	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	2.72e-05	0.000184	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.68e-05	0.000182	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.64e-05	0.000179	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.62e-05	0.000178	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.44e-05	0.000166	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.39e-05	0.000162	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.33e-05	0.000158	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.29e-05	0.000155	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.28e-05	0.000155	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.24e-05	0.000152	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.96e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	1.92e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.92e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	1.87e-05	0.000127	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.71e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.67e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.65e-05	0.000112	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.64e-05	0.000111	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.61e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.6e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.58e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.58e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.55e-05	0.000105	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.55e-05	0.000105	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.5e-05	0.000102	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.47e-05	9.98e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.21e-05	8.21e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.18e-05	8.04e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.03e-05	7.02e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.01e-05	6.86e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	7.15e-06	4.85e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	7e-06	4.75e-05	CbGpPWpGaD
